{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:07:29Z","timestamp":1790431649762,"version":"4.1.0"},"reference-count":73,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Adult T-cell leukemia (ATL), a CD4<jats:sup>+<\/jats:sup>-T-cell malignancy caused by human T-cell leukemia virus type 1 (HTLV-1), is difficult to cure, and novel treatments are urgently needed. Apo2 ligand (Apo2L; also tumor necrosis factor-related apoptosis-inducing ligand [TRAIL]) has been implicated in antitumor therapy. We found that HTLV-1-infected T-cell lines and primary ATL cells were more resistant to Apo2L-induced apoptosis than uninfected cells. Interestingly, HTLV-1-infected T-cell lines and primary ATL cells constitutively expressed Apo2L mRNA. Inducible expression of the viral oncoprotein Tax in a T-cell line up-regulated Apo2L mRNA. Analysis of the Apo2L promoter revealed that this gene is activated by Tax via the activation of NF-\u03baB. The sensitivity to Apo2L was not correlated with expression levels of Apo2L receptors, intracellular regulators of apoptosis (FLICE-inhibitory protein and active Akt). NF-\u03baB plays a crucial role in the pathogenesis and survival of ATL cells. The resistance to Apo2L-induced apoptosis was reversed by<jats:italic>N<\/jats:italic>-acetyl-<jats:sc>l<\/jats:sc>-leucinyl-<jats:sc>l<\/jats:sc>-leucinyl-<jats:sc>l<\/jats:sc>-norleucinal (LLnL), an NF-\u03baB inhibitor. LLnL significantly induced the Apo2L receptors DR4 and DR5. Our results suggest that the constitutive activation of NF-\u03baB is essential for<jats:italic>Apo2L<\/jats:italic>gene induction and protection against Apo2L-induced apoptosis and that suppression of NF-\u03baB may be a useful adjunct in clinical use of Apo2L against ATL.<\/jats:p>","DOI":"10.1128\/jvi.79.3.1367-1378.2005","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T20:08:36Z","timestamp":1105646916000},"page":"1367-1378","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":22,"title":["Resistance to Apo2 Ligand (Apo2L)\/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Mediated Apoptosis and Constitutive Expression of Apo2L\/TRAIL in Human T-Cell Leukemia Virus Type 1-Infected T-Cell Lines"],"prefix":"10.1128","volume":"79","author":[{"given":"Takehiro","family":"Matsuda","sequence":"first","affiliation":[{"name":"Division of Molecular Virology and Oncology, Graduate School of Medicine"},{"name":"Division of Child Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Almasan","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Tomita","sequence":"additional","affiliation":[{"name":"Division of Molecular Virology and Oncology, Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-nosuke","family":"Uchihara","sequence":"additional","affiliation":[{"name":"Division of Molecular Virology and Oncology, Graduate School of Medicine"},{"name":"Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Masuda","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuiku","family":"Ohshiro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Naha Prefectural Hospital, Naha, Okinawa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Takasu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Faculty of Medicine, University of the Ryukyus, Nishihara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yagita","sequence":"additional","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Ohta","sequence":"additional","affiliation":[{"name":"Division of Child Health and Welfare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Molecular Virology and Oncology, Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.11.4243.bloodjournal86114243"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(03)00029-7"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6926"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.6.3164"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.5.2809"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80400-8"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204736"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.17.8135-8139.2000"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80399-4"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401501"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.9.5157"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.225"},{"key":"e_1_3_2_14_2","first-page":"488","volume":"62","year":"2002","unstructured":"Gibson, E. M., E. S. Henson, N. Haney, J. Villanueva, and S. B. Gibson. 2002. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res.62:488-496.","journal-title":"Cancer Res."},{"key":"e_1_3_2_15_2","first-page":"6153","volume":"59","year":"1999","unstructured":"Gliniak, B., and T. Le. 1999. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res.59:6153-6158.","journal-title":"Cancer Res."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3872"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(98)80224-0"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","volume":"161","year":"1998","unstructured":"Griffith, T. S., W. A. Chin, G. C. Jackson, D. H. Lynch, and M. Z. Kubin. 1998. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol.161:2833-2840.","journal-title":"J. Immunol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6476"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.153.2.566","volume":"153","year":"1994","unstructured":"Hollsberg, P., L. J. Ausubel, and D. A. Hafler. 1994. Human T cell lymphotropic virus type I-infected T cell activation: resistance to TGF-\u03b21-induced suppression. J. Immunol.153:566-573.","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/40657"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.12.4624"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7518614"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.18.1.621"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.8.1311"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.8.1365"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.4049\/jimmunol.162.5.2639","volume":"162","year":"1999","unstructured":"Kayagaki, N., N. Yamaguchi, M. Nakayama, A. Kawasaki, H. Akiba, K. Okumura, and H. Yagita. 1999. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity. J. Immunol.162:2639-2647.","journal-title":"J. Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.4049\/jimmunol.163.4.1906","volume":"163","year":"1999","unstructured":"Kayagaki, N., N. Yamaguchi, M. Nakayama, K. Takeda, H. Akiba, H. Tsutsui, H. Okamura, K. Nakanishi, K. Okumura, and H. Yagita. 1999. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol.163:1906-1913.","journal-title":"J. Immunol."},{"key":"e_1_3_2_29_2","first-page":"335","volume":"6","year":"2000","unstructured":"Kim, K., M. J. Fisher, S. Q. Xu, and W. S. el-Deiry. 2000. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin. Cancer Res.6:335-346.","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.1.121"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.2.482.482"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90066-3"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.5.1080.1080"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9319"},{"key":"e_1_3_2_35_2","first-page":"553","volume":"60","year":"2000","unstructured":"Leverkus, M., M. Neumann, T. Mengling, C. T. Rauch, E. B. Brocker, P. H. Krammer, and H. Walczak. 2000. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res.60:553-559.","journal-title":"Cancer Res."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204364"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/370650a0"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(09)00456-4"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.6.4445-4451.1997"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.5.2083"},{"key":"e_1_3_2_41_2","first-page":"155","volume":"71","year":"1980","unstructured":"Miyoshi, I., I. Kubonishi, M. Sumida, S. Hiraki, T. Tsubota, I. Kimura, K. Miyamoto, and J. Sato. 1980. A novel T-cell line derived from adult T-cell leukemia. Jpn. J. Cancer Res.71:155-156.","journal-title":"Jpn. J. Cancer Res."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/294770a0"},{"key":"e_1_3_2_43_2","first-page":"2360","volume":"93","year":"1999","unstructured":"Mori, N., M. Fujii, S. Ikeda, Y. Yamada, M. Tomonaga, D. W. Ballard, and N. Yamamoto. 1999. Constitutive activation of NF-\u03baB in primary adult T-cell leukemia cells. Blood93:2360-2368.","journal-title":"Blood"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0151"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.8.3220-3226.1989"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2888190"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005196200"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.4.1589"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5327.815"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5309.111"},{"key":"e_1_3_2_51_2","first-page":"4119","volume":"6","year":"2000","unstructured":"Petak, I., L. Douglas, D. M. Tillman, R. Vernes, and J. A. Houghton. 2000. Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis. Clin. Cancer Res.6:4119-4127.","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.34.21096"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6600519"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-200110000-00005"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80401-X"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4049\/jimmunol.163.2.920","volume":"163","year":"1999","unstructured":"Sedger, L. M., D. M. Shows, R. A. Blanton, J. J. Peschon, R. G. Goodwin, D. Cosman, and S. R. Wiley. 1999. IFN-\u03b3 mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol.163:920-926.","journal-title":"J. Immunol."},{"key":"e_1_3_2_58_2","first-page":"1059","volume":"11","year":"1997","unstructured":"Seth, A., C. Zhang, N. L. Letvin, and S. F. Schlossma. 1997. Detection of apoptotic cells from peripheral blood of HIV-infected individuals using a novel monoclonal antibody. AIDS11:1059-1061.","journal-title":"AIDS"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5327.818"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.4.11.1875"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M103321200"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.161.5.2195","volume":"161","year":"1998","unstructured":"Thomas, W. D., and P. Hersey. 1998. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J. Immunol.161:2195-2200.","journal-title":"J. Immunol."},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.1.556-559.2000"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.17.5386"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90057-8"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5339.866"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02737.x"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6980467"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00422.x"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.6.2031"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.7.4547"},{"key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.4049\/jimmunol.157.9.3980","volume":"157","year":"1996","unstructured":"Zhang, C., Z. Ao, A. Seth, and S. F. Schlossman. 1996. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells. J. Immunol.157:3980-3987.","journal-title":"J. Immunol."},{"key":"e_1_3_2_73_2","first-page":"2747","volume":"59","year":"1999","unstructured":"Zhang, X. D., A. Franco, K. Myers, C. Gray, T. Nguyen, and P. Hersey. 1999. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res.59:2747-2753.","journal-title":"Cancer Res."},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.8.3961"}],"updated-by":[{"DOI":"10.1128\/jvi.02070-10","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"record-id":"2462"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.3.1367-1378.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.3.1367-1378.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T15:24:19Z","timestamp":1682954659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.79.3.1367-1378.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1128\/JVI.79.3.1367-1378.2005"],"URL":"https:\/\/doi.org\/10.1128\/jvi.79.3.1367-1378.2005","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"2004-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-09-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}